Novel immunoregulatory properties of EGCG on reducing inflammation in EAE

Frontiers in Bioscience

Volumn 18, Issue 1, 2013, Pages 332-342

  Sun, Quanye ^a,b   Zheng, Yingxia ^a   Zhang, Xia ^a,c   Hu, Xiaojuan ^a   Wang, Yuanxia ^a   Zhang, Shimin ^d   Zhang, Dongqing ^a   Nie, Hong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SHENZHEN CHILDREN'S HOSPITAL   (China)

^d Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

APC; EGCG; Experimental autoimmune encephalomyelitis; Th1; Th17

Indexed keywords

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; STAT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DRUG EFFECT; IMMUNOLOGY; MALE; MOUSE; MULTIPLE SCLEROSIS; PHYSIOLOGY; TH17 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; CATECHIN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; STAT TRANSCRIPTION FACTORS; TH17 CELLS;

MLCS; MLOWN;

EID: 84878797867     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4104     Document Type: Article

References (36)

1. J. Goverman: Autoimmune T cell responses in the central nervous system. Nat Rev Immunol, 9(6), 393-407 (2009)
2. J. M. Fletcher, S. J. Lalor, C. M. Sweeney, N. Tubridy and K. H. Mills: T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol, 162(1), 1-11 (2010)
3. Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo and Y. Iwakura: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol, 177(1), 566-573 (2006)
4. H. H. Hofstetter, S. M. Ibrahim, D. Koczan, N. Kruse, A. Weishaupt, K. V. Toyka and R. Gold: Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol, 237(2), 123-130 (2005)
5. B. M. Segal: Th17 cells in autoimmune demyelinating disease. Semin Immunopathol, 32(1), 71-77 (2010)
6. H. Hofstetter, R. Gold and H. P. Hartung: Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J, 16(1), 12-18 (2009)
7. M. El-behi, A. Rostami and B. Ciric: Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol, 5(2), 189-197 (2010)
8. B. T. Ji, W. H. Chow, A. W. Hsing, J. K. McLaughlin, Q. Dai, Y. T. Gao, W. J. Blot and J. F. Jr. Fraumeni: Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer, 70(3), 255-258 (1997)
9. H. Tachibana: Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci, 87(3), 66-80 (2011)
10. Y. H. Kao, H. H. Chang, M. J. Lee and C. L. Chen: Tea, obesity, and diabetes. Mol Nutr Food Res, 50(2), 188-210 (2006)
11. R. Singh, N. Akhtar and T. M. Haqqi: Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. Life Sci, 86(25-26), 907-918 (2010)
12. J. D. Lambert and C. S. Yang: Mechanisms of cancer prevention by tea constituents. J Nutr, 133(10), 3262S-3267S (2003)
13. S. K. Lin, H. H. Chang, Y. J. Chen, C. C. Wang, D. L. Galson, C. Y. Hong and S. H. Kok: Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis. Arthritis Rheum, 58(10), 3145-3156 (2008)
14. Y. Wang, Y. Mei, D. Feng and L. Xu: (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury. Clin Exp Immunol, 145(3), 485-492 (2006)
15. K. Gillespie, I. Kodani, D. P. Dickinson, K. U. Ogbureke, A. M. Camba, M. Wu, S. Looney, T. C. Chu, H. Qin, F. Bisch, M. Sharawy, G. S. Schuster and S. D. Hsu: Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci, 83(17-18), 581-588 (2008)
16. Z. H. Ran, C. Chen and S. D. Xiao: Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother, 62(3), 189-196 (2008)
17. T. M. Haqqi, D. D. Anthony, S. Gupta, N. Ahmad, M. S. Lee, G. K. Kumar and H. Mukhtar: Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA, 96(8), 4524-4529 (1999)
18. O. Aktas, T. Prozorovski, A. Smorodchenko, N. E. Savaskan, R. Lauster, P. Kloetzel, C. Infante-Duarte, S. Brocke and F. Zipp: Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol, 173(9), 5794-5800 (2004)
19. A. Salahuddin: Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise. Arthritis Res Ther, 12(2), 208 (2010)
20. J. D. Lambert and R. J. Elias: The antioxidant and prooxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys, 501(1), 65-72 (2010)
21. L. Nagelkerken: Role of Th1 and Th2 cells in autoimmune demyelinating disease. Braz J Med Biol Res, 31(1), 55-60 (1998)
22. M. Falcone and B. R. Bloom: A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med, 185(5), 901-907 (1997)
23. T. Aranami and T. Yamamura: Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int, 57(2), 115-120 (2008)
24. N. Nath, R. Prasad, S. Giri, A. K. Singh and I. Singh: Tbet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology, 118(3), 384-391 (2006)
25. I. I. Ivanov, B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua and D. R. Littman: The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 126(6), 1121-1133 (2006)
26. S. L. Peng: The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol, 3(2), 87-95 (2006)
27. Z. Chen, A. Laurence and J. J. O'Shea: Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol, 19(6), 400-408 (2007)
28. J. S. Rawlings, K. M. Rosler and D. A. Harrison: The JAK/STAT signaling pathway. J Cell Sci, 117(Pt 8), 1281-1283 (2004)
29. X. O. Yang, A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich and C. Dong: STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem, 282(13), 9358-9563 (2007)
30. L. Durant, W. T. Watford, H. L. Ramos, A. Laurence, G. Vahedi, L. Wei, H. Takahashi1, H. Sun, Y. Kanno, F. Powrie and J. J. O'Shea: Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity, 32(5), 605-615 (2010)
31. M. Pae, Z. Ren, M. Mwydani, F. Shang, S. N. Meydani and D. Wu: Epigallocatechin-3-Gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression. J Nutr, 140(8), 1509-1515 (2010)
32. Z. Szekanecz, A. Vegvari, Z. Szabo and A. E. Koch: Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed), 2, 153-167 (2010).
33. A. Szczucinski and J. Losy: Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand, 115(3), 137-146 (2007)
34. B. Engelhardt: Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm, 113(4), 477-485 (2006)
35. B. T. Fife, M. C. Paniagua, N. W. Lukacs, S. L. Kunkel and W. J. Karpus: Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J Neurosci Res, 66(4), 705-714 (2001)
36. R. E. Dogan and W. J. Karpus: Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation. Front Biosci, 9, 1500-1505 (2004)